Activity Provided By:

Annenberg Center for Health Sciences at Eisenhower

Advanced Ovarian Cancer and PARP Inhibitors: Clinical Insights and Impact on New Data

Overview / Abstract:	In this CME activity, Susana M. Campos, MD, MS, MPH, reviews some of the recent clinical developments in the treatment of patients with advanced ovarian cancer with PARP inhibitors. We welcome you to learn more about the updated data from key clinical studies of PARP inhibitor maintenance therapy in advanced ovarian cancer, and the implications of the results on the current and emerging concepts in ovarian cancer clinical practice. CONTENT AREAS • Platinum-sensitive recurrent ovarian cancer • Advanced ovarian cancer with BRCA mutation • PARP inhibitor maintenance therapy • Patient-reported outcomes • Individualized PARP inhibitor dosing • Long-term safety and tolerability
Expiration	Sep 30, 2022
Discipline(s)	Nurse Practitioner , Physician CME
Format	Webinar / Webcast / Video
Credits / Hours	.50 credit hrs
Accreditation	ACCME
Presenters / Authors / Faculty	Susana Campos, MD, MS, MPH Assistant Professor, Medicine Harvard Medical School Boston, Massachusetts Director, Dartmouth Headache Center Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire Gregory Scott, PharmD WriteHealth, LLC Kennebunk, Maine
Activity Specialities / Related Topics	OB/GYN / Women's Health, Oncology / Cancer / Radiation Therapy, Pathology, Radiology / Imagery / Nuclear Medicine
Sponsors / Supporters / Grant Providers	This educational activity is supported by an educational grant from GlaxoSmithKline.
Keywords / Search Terms	Annenberg Center for Health Sciences at Eisenhower Ovarian Cancer PARP Inhibitors Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map